Financial statements Dermie Pharm
Balance sheet data of DERMIE PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 38 369,25 | 29 780,37 | 92 937,59 | 142 214,97 | 112 034,40 | 108 905,37 |
| A. Fixed assets | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 |
| B. Current assets | 37 369,25 | 28 780,37 | 91 937,59 | 141 214,97 | 111 034,40 | 107 905,37 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 38 369,25 | 29 780,37 | 92 937,59 | 142 214,97 | 112 034,40 | 108 905,37 |
| A. Equity | 37 606,25 | 29 144,37 | 21 609,10 | 121 320,17 | 111 419,40 | -509,03 |
| B. Liabilities and provisions for liabilities | 763,00 | 636,00 | 71 328,49 | 20 894,80 | 615,00 | 109 414,40 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.